Horizon Pharma, Inc. et al v. Dr. Reddy's Laboratories Inc. et al

MOTION to Dismiss for Lack of Jurisdiction

D.N.J.April 25, 2017

1132075 Alan H. Pollack (apollack@buddlarner.com) CONTAINS CONFIDENTIAL Dmitry V. Shelhoff (dshelhoff@buddlarner.com) INFORMATION -- PORTIONS Stephanie J. Kamerow (skamerow@buddlarner.com) FILED UNDER SEAL Budd Larner, P.C. 150 John F. Kennedy Parkway Short Hills, NJ 07078 (973) 379-4800 Attorneys for Defendants Dr. Reddy’s Laboratories, Ltd. and Dr. Reddy’s Laboratories, Inc. UNITED STATES DISTRICT COURT FOR THE DISTRICT OF NEW JERSEY HORIZON PHARMA, INC., HORIZON PHARMA USA, INC. and POZEN INC., Plaintiffs, v. DR. REDDY’S LABORATORIES, INC. and DR. REDDY’S LABORATORIES, Defendants. Civil Action No. 3:16-cv-4918 (MLC)(DEA) Civil Action No. 3:16-cv-9035 (MLC)(DEA) ELECTRONICALLY FILED MOTION DATE: JUNE 5, 2017 ORAL ARGUMENT REQUESTED NOTICE OF MOTION OF DEFENDANTS’ DR. REDDY’S LABORATORIES, LTD. AND DR. REDDY’S LABORATORIES, INC. TO DISMISS ALLEGATIONS OF INFRINGEMENT OF THE ‘621 PATENT BASED ON DRL’S SECTION VIII FILING PLEASE TAKE NOTICE that on June 5, 2017, or as soon thereafter as counsel may be heard, the undersigned attorneys for Dr. Reddy’s Laboratories, Ltd., and Dr. Reddy’s Laboratories, Inc., (together, “DRL”) will move before the Honorable Mary L. Cooper, United States District Judge (i) pursuant to Fed. R. Civ. P. 12(c), for judgment on the pleadings dismissing Counts I and II of the complaint of Plaintiffs Horizon Pharma, Inc., Horizon Pharma Case 3:16-cv-04918-MLC-DEA Document 54 Filed 04/25/17 Page 1 of 3 PageID: 1097 2 1132075 USA, Inc., and Pozen, Inc., filed in the 3:16-cv-4918 action, for failure to state a claim upon which relief can be granted, and/or (ii) to dismiss Count II of the complaint in the 3:16-cv-4918 action pursuant to Fed. R. Civ. P. 12(b)(1) for lack of subject matter jurisdiction. PLEASE TAKE FURTHER NOTICE that in support of this motion, DRL will rely upon its Memorandum of Law, the Declaration of Dmitry V. Shelhoff together with all exhibits thereto, and DRL’s reply papers, if any. PLEASE TAKE FURTHER NOTICE that pursuant to Rule 7.1(e) of the Local Rules of the District of New Jersey, a proposed form of order is being submitted concurrently with this motion. Dated: April 24, 2017 Respectfully submitted, By: s/ Alan H. Pollack Alan H. Pollack (apollack@buddlarner.com) Dmitry V. Shelhoff (dshelhoff@buddlarner.com) Stephanie J. Kamerow (skamerow@buddlarner.com) BUDD LARNER, P.C. 150 John F. Kennedy Parkway Short Hills, New Jersey 07078 Tel: (973) 379-4800 Attorneys for Defendants Dr. Reddy’s Laboratories, Ltd. and Dr. Reddy’s Laboratories, Inc. Case 3:16-cv-04918-MLC-DEA Document 54 Filed 04/25/17 Page 2 of 3 PageID: 1098 3 1132075 CERTIFICATE OF SERVICE I, Dmitry Shelhoff, hereby certify that on April 24, 2017, I caused a true and correct copy of Defendants’ Notice of Motion to Dismiss Allegations of Infringement of the ‘621 Patent Based on DRL’s Section viii Filing to be served via ECF and e-mail on counsel for Plaintiffs: John E. Flaherty Ravin R. Patel McCarter & English, LLP Four Gateway Center 100 Mulberry Street Newark, New Jersey 07102 (973) 622-4444 Attorneys for Plaintiffs Horizon Pharma, Inc. and Horizon Pharma USA, Inc., and Pozen Inc. James B. Monroe Danielle C. Pfifferling Finnegan, Henderson, Farabow, Garrett & Dunner, LLP 901 New York Avenue, NW, Washington, DC 20001-4413 Attorneys for Plaintiffs Horizon Pharma, Inc. and Horizon Pharma USA, Inc. Ellen Scordino Cooley LLP 500 Boylston Street, 14th Floor Boston, MA 02116-3736 Attorneys for Plaintiffs Horizon Pharma, Inc. and Horizon Pharma USA, Inc. Stephen M. Hash Jeff Gritton Baker Botts, LLP 98 San Jacinto Blvd #1500 Austin, TX 78701 Attorneys for Plaintiffs Pozen Inc. s/Dmitry Shelhoff Dmitry Shelhoff Case 3:16-cv-04918-MLC-DEA Document 54 Filed 04/25/17 Page 3 of 3 PageID: 1099